Search Results 1561-1570 of 16099 for Epilepsy (Partial Onset)

  1. Stereotactic radiosurgery - Care at Mayo Clinic

    ... epilepsy and psychological disorders such as obsessive-compulsive disorder. This emphasis on research increases the treatment choices available to Mayo ...

  2. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

    ... duration, antibiotic type, and dose at the discretion of the Investigator); AND; Subject has had an adequate clinical response, defined as ≤ 3 unformed ...

  3. Precision Medicine for Obesity - Clinical Trials

    Patients also use activity trackers that are paired to an application on their iPhone for the duration of the study. After completing testing and being ...

  4. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    This is a two arm Phase III trial in first and second-line HER2 negative patients with locally recurrent or metastatic breast cancer. The primary endpoint is ...

  5. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Confirmed COVID-19: the Baseline visit must be at least 14 days from onset of signs/symptoms or positive SARS-CoV-2 test, symptomatic subjects must have ...

  6. A Study to Evaluate the Safety and Effectiveness of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia - Mayo Clinic

    Participation eligibility · Activated partial thromboplastin time (aPTT) that exceeds ULN values by more than 5 seconds; · Prothrombin time (PT) expressed as ...

  7. Publications - Allison C. Rosenthal, D.O. - Mayo Clinic

    ... onset asthma and periocular xanthogranuloma: Case report of 3 uncommon clinical entities. ... Assessment of fixed-duration therapies for treatment-naive ...

  8. A Study to Evaluate the Combination of Selinexor with Pomalidomide and Dexamethasone +/- Carfilzomib to Treat Patients with Refractory Multiple Myeloma - Mayo Clinic

    - Willingness to use fixed-duration therapy (up to 18 cycles) for relapsed refractory ... Prothrombin time (PT)/international normalized ratio (INR)/activated ...

  9. Metastatic Melanoma Clinical Trials

    The dosing, duration, regimen, indication, and treatments will be observed. ... partial response (PR))across both standard of ... Additinoally, to evaluate the ...

  10. Publications - Brian A. Neff, M.D. - Mayo Clinic

    New onset tinnitus in the absence of hearing changes following COVID-19 infection. Am J Otolaryngol. 2022 Jan-Feb; 43 (1):103208 Epub 2021 Sept 10. View ...